Stay updated with breaking news from Nasdaq Cgem. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cullinan Oncology, Inc. (NASDAQ:CGEM – Get Free Report) CFO Jeffrey Trigilio sold 1,926 shares of the stock in a transaction that occurred on Tuesday, December 12th. The shares were sold at an average price of $7.81, for a total value of $15,042.06. Following the sale, the chief financial officer now owns 86,237 shares of the […]
SVB Financial Group decreased its position in Cullinan Oncology, Inc. (NASDAQ:CGEM – Free Report) by 33.3% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 13,516 shares of the company’s stock after selling 6,758 shares during the period. Cullinan Oncology […]
Cullinan Oncology, Inc. (NASDAQ:CGEM – Get Free Report) was the recipient of a large decline in short interest in the month of September. As of September 15th, there was short interest totalling 2,180,000 shares, a decline of 17.7% from the August 31st total of 2,650,000 shares. Based on an average trading volume of 189,900 shares, […]
EcoR1 Capital LLC cut its stake in shares of Cullinan Oncology, Inc. (NASDAQ:CGEM – Free Report) by 76.2% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 246,410 shares of the company’s stock after selling 788,628 shares during the quarter. EcoR1 […]
EcoR1 Capital LLC cut its holdings in Cullinan Oncology, Inc. (NASDAQ:CGEM – Free Report) by 76.2% during the first quarter, Holdings Channel reports. The institutional investor owned 246,410 shares of the company’s stock after selling 788,628 shares during the quarter. EcoR1 Capital LLC’s holdings in Cullinan Oncology were worth $2,521,000 at the end of the […]